Glycyrrhizin as a nitric oxide regulator in cancer chemotherapyopen access
- Authors
- Kim, Minsu; Park, Seok Chan; Lee, Dong Yun
- Issue Date
- Nov-2021
- Publisher
- MDPI
- Keywords
- ATP-biding cassette; Chemotherapy; Glycyrrhizin; Multidrug resistance; Nitric oxide; Tumor microenvironment
- Citation
- Cancers, v.13, no.22, pp.1 - 22
- Indexed
- SCIE
SCOPUS
- Journal Title
- Cancers
- Volume
- 13
- Number
- 22
- Start Page
- 1
- End Page
- 22
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/140442
- DOI
- 10.3390/cancers13225762
- ISSN
- 2072-6694
- Abstract
- Chemotherapy is used widely for cancer treatment; however, the evolution of multidrug resistance (MDR) in many patients limits the therapeutic benefits of chemotherapy. It is important to overcome MDR for enhanced chemotherapy. ATP-dependent efflux of drugs out of cells is the main mechanism of MDR. Recent studies have suggested that nitric oxide (NO) can be used to overcome MDR by inhibiting the ATPase function of ATP-dependent pumps. Several attempts have been made to deliver NO to the tumor microenvironment (TME), however there are limitations in delivery. Glycyrrhizin (GL), an active compound of licorice, has been reported to both reduce the MDR effect by inhibiting ATP-dependent pumps and function as a regulator of NO production in the TME. In this review, we describe the potential role of GL as an NO regulator and MDR inhibitor that efficiently reduces the MDR effect in cancer chemotherapy.
- Files in This Item
-
- Appears in
Collections - 서울 공과대학 > 서울 생명공학과 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/140442)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.